The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.
about
The role of the Asn40Asp polymorphism of the mu opioid receptor gene (OPRM1) on alcoholism etiology and treatment: a critical reviewThe evolution of vertebrate opioid receptorsPain-related effects of trait anger expression: neural substrates and the role of endogenous opioid mechanismsCortisol Stress Response in Men and Women Modulated Differentially by the Mu-Opioid Receptor Gene Polymorphism OPRM1 A118G.The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction.Pharmacogenetics of OPRM1.Association of Variants of Arginine Vasopressin and Arginine Vasopressin Receptor 1A With Severe Acetaminophen Liver Injury.Mu-opioid receptor (OPRM1) variation, oxytocin levels and maternal attachment in free-ranging rhesus macaques Macaca mulattaA cis-eQTL in OPRM1 is Associated with Subjective Response to Alcohol and Alcohol Use.Drug-induced and genetic alterations in stress-responsive systems: Implications for specific addictive diseases.OPRM1 SNP (A118G): involvement in disease development, treatment response, and animal models.Functional polymorphism of the mu-opioid receptor gene (OPRM1) influences reinforcement learning in humans.A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.Epigenetic variation in the mu-opioid receptor gene in infants with neonatal abstinence syndromeGenetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence.The interpersonal dimension of borderline personality disorder: toward a neuropeptide model.The μ-opioid receptor variant N190K is unresponsive to peptide agonists yet can be rescued by small-molecule drugs.Pharmacogenomic considerations in opioid analgesia.Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine.Buprenorphine signalling is compromised at the N40D polymorphism of the human μ opioid receptor in vitroAssociation study of OPRM1 polymorphisms with Schizophrenia in Han Chinese population.Child μ-opioid receptor gene variant influences parent-child relations.Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human μ-opioid receptor (OPRM1)Litter gender composition and sex affect maternal behavior and DNA methylation levels of the oprm1 gene in rat offspring.Using the Phenogen website for 'in silico' analysis of morphine-induced analgesia: identifying candidate genes.Functional characteristics of the naked mole rat μ-opioid receptor.Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measuresOPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques.Genetic Variation of the Mu Opioid Receptor (OPRM1) and Dopamine D2 Receptor (DRD2) is Related to Smoking Differences in Patients with Schizophrenia but not Bipolar DisorderMouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type miceGenotyping test with clinical factors: better management of acute postoperative pain?Pharmacological consequence of the A118G μ opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca²⁺ channels in humanized mouse sensory neurons.Association of OPRM1 A118G variant with risk of morphine-induced respiratory depression following spine fusion in adolescents.Association between Opioid Receptor mu 1 (OPRM1) Gene Polymorphisms and Tobacco and Alcohol Consumption in a Spanish Populationμ-Opioid Receptor Gene A118 G Variants and Persistent Pain Symptoms Among Men and Women Experiencing Motor Vehicle CollisionCis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1Tissue-Specific Glycosylation at the Glycopeptide Level.Addiction pharmacogenetics: a systematic review of the genetic variation of the dopaminergic systemReceptor Reserve Moderates Mesolimbic Responses to Opioids in a Humanized Mouse Model of the OPRM1 A118G PolymorphismPharmacogenetic approaches to the treatment of alcohol addiction.
P2860
Q24616528-2E2D50E1-C8F6-4EC8-91C7-7212DB8F1616Q24627645-33B3C013-C0FA-4A15-B68F-B50165A6FF2BQ24658054-663630A5-94AF-4EB7-B0B3-4830C53FC293Q27311002-8F816105-7889-42CB-BBE1-24BCDD40F2A5Q33455500-1E02D852-8542-48AE-A321-4C1356562B2EQ33568294-14A8EBB8-4148-47A1-AC87-6D874DEC03FAQ33600448-8699A4B5-B139-4B49-812E-97F3E158E72CQ33601182-A01A0058-137A-41A5-89BF-B03FB3EC6CABQ33603061-45CB685A-BA97-4A45-8D59-036E9F22FDA6Q33643136-432C673D-39A8-474A-BE29-26B2AB65C65AQ33921223-7563EBB4-1D14-4851-94AB-2AA4008CA5C1Q34017870-F1FB9E11-29A4-4FC6-B726-E2C46887B50FQ34037595-75E422CB-1654-4F91-A62B-95278EA7A125Q34090556-F5C34678-D14B-4770-AE9D-4E7CF9BE976AQ34139876-1B0C5589-E1FA-4FFF-A2AE-73C123634D03Q34252326-1C38F967-750A-4F46-B842-3BB5E0532EB1Q34309916-A4393D28-A8E6-4325-A30B-BF0013A20BBBQ34316700-87F2313B-B536-4A3C-ADAC-B5EE452471CAQ34330604-BB3A5F6C-A8D1-4E9D-9490-9CE60526239AQ34559598-554AA820-A278-42FD-97A0-009D7F763409Q34656692-731E1EF2-99F8-4823-BA5B-2EEDE6EA2836Q34798577-EF138561-8182-4923-9E5A-FBDEC5522704Q34939590-77FB81AC-F1A0-4094-B1EB-646E624EA26EQ34994721-BB60F3BC-93A3-4B4A-8810-9922270FAFABQ35046317-356C462B-B2E2-4535-BDBB-A3E1C59D083AQ35060169-BBD4502D-AB21-4647-865D-D286E5C5454FQ35089406-B639A4B6-18E3-4C92-9E8A-30936A4AF7E9Q35091270-D449BE7D-D681-452C-A605-3EACD45D7EA3Q35196495-B485CBC8-7900-4130-B42E-4EEB82ACA388Q35199976-99A62C68-BE11-437F-A98E-7FFCB6B00DE6Q35381687-A47B72BD-D445-4003-94A3-D8C8F3B51F81Q35464108-DBDC41A2-9AAE-4BCF-BF20-D47837D4F3A4Q35528692-3F988D8A-95BF-49E6-89A8-C8C89E71BA34Q35749819-53874C89-C229-4D64-8FAA-7D3C2C9D8D32Q35801850-0C312E67-DDDE-43A4-A939-FB1CC8051E92Q35901259-2A2F5442-9692-4D1F-ADE3-9DCDE37145FFQ35926188-15B0B5D5-D6E8-4B4F-B501-6F2E9BE59A84Q35995415-00829E8A-13D3-4B2F-B8AF-63A4A1BD69F2Q36059914-2CDD3C67-CCF3-494A-ADFA-E350AD9E6151Q36126591-5C74246C-2D6D-428D-9942-978FABB3E72B
P2860
The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The single nucleotide polymorp ...... the human mu opioid receptor.
@en
type
label
The single nucleotide polymorp ...... the human mu opioid receptor.
@en
prefLabel
The single nucleotide polymorp ...... the human mu opioid receptor.
@en
P2093
P2860
P1476
The single nucleotide polymorp ...... the human mu opioid receptor.
@en
P2093
David A Nielsen
K Steven Laforge
Robert J Gianotti
Thomas Kroslak
P2860
P356
10.1111/J.1471-4159.2007.04738.X
P407
P577
2007-10-01T00:00:00Z